Mimedx (MDXG) EBT Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9,460.35% |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -278.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -278.02% |
| Dec 31, 2025 | 93.75% |
| Sep 30, 2025 | 100.10% |
| Jun 30, 2025 | -43.97% |
| Mar 31, 2025 | -24.52% |
| Dec 31, 2024 | -19.15% |
| Sep 30, 2024 | 21.05% |
| Jun 30, 2024 | 152.98% |
| Mar 31, 2024 | 703.33% |
| Dec 31, 2023 | 41.13% |
| Sep 30, 2023 | 212.66% |
| Jun 30, 2023 | 184.93% |
| Mar 31, 2023 | 81.86% |
| Dec 31, 2022 | 10,732.97% |
| Sep 30, 2022 | -310.84% |
| Jun 30, 2022 | -505.72% |
| Mar 31, 2022 | -25.25% |
| Dec 31, 2021 | 100.52% |
| Sep 30, 2021 | 89.48% |
| Jun 30, 2021 | 78.86% |
| Mar 31, 2021 | 48.38% |
| Dec 31, 2020 | -142.56% |
| Sep 30, 2020 | -260.56% |
| Jun 30, 2020 | 50.84% |
| Mar 31, 2020 | -21.87% |
| Dec 31, 2019 | 16.86% |
| Sep 30, 2019 | 2,457.20% |
| Jun 30, 2019 | -1,058.57% |
| Mar 31, 2019 | -531.40% |
| Dec 31, 2018 | -146.15% |
| Sep 30, 2018 | -96.39% |
| Jun 30, 2018 | -74.65% |
| Mar 31, 2018 | -49.22% |
| Dec 31, 2017 | 311.71% |
| Sep 30, 2017 | 183.21% |
| Jun 30, 2017 | 104.75% |
| Mar 31, 2017 | 328.07% |
| Dec 31, 2016 | -216.26% |
| Sep 30, 2016 | -31.20% |
| Jun 30, 2016 | -38.97% |
| Mar 31, 2016 | -66.67% |
| Dec 31, 2015 | 65.47% |
| Sep 30, 2015 | 80.25% |
| Jun 30, 2015 | 1,513.25% |
| Mar 31, 2015 | 564.14% |
| Dec 31, 2014 | 426.04% |
| Sep 30, 2014 | 1,529.24% |
| Jun 30, 2014 | 47.19% |
| Mar 31, 2014 | 41.92% |
| Dec 31, 2013 | 11.32% |
| Sep 30, 2013 | 93.83% |
| Jun 30, 2013 | -1.79% |
| Mar 31, 2013 | -43.57% |
| Dec 31, 2012 | 37.69% |
| Sep 30, 2012 | -138.96% |
| Jun 30, 2012 | 70.28% |
| Mar 31, 2012 | 67.33% |